U.S. pharmaceutical industry is studied

Oct 12, 2006

A new study concludes the U.S. pharmaceutical industry might be wasting more than $50 billion every year in manufacturing expenses.

The finding is part of the largest empirical study ever performed of pharmaceutical manufacturing and the U.S. Food and Drug Administration's monitoring policies.

The study was conducted by Jackson Nickerson, professor of organization and strategy at Washington University in St. Louis, and Jeffrey Macher, assistant professor of strategy and economics at Georgetown University.

"We undertook the project to understand how the FDA regulates and pharmaceutical manufacturers produce, so we could see where there may be conflicts that inhibit advances in manufacturing," Nickerson said. "Our policy goal is to understand both sides of the coin so that we could contribute to improving the regulatory environment, thereby altering the pharmaceutical industry's incentives to maintain and in some cases enhance product quality but for a much lower cost."

The researchers collected data from 42 manufacturing facilities and determined companies extensively using information technology displayed superior manufacturing performance compared with other firms.

They also found the lower in the ranks a company allows employees to make decisions, the higher the company's overall manufacturing performance.

Copyright 2006 by United Press International

Explore further: Radiologist recommendations for chest CT have high clinical yield

add to favorites email to friend print save as pdf

Related Stories

Study 'makes the case' for RFID forensic evidence management

Dec 05, 2014

Radio frequency identification (RFID) tags—devices that can transmit data over short distances to identify objects, animals or people—have become increasingly popular for tracking everything from automobiles being manufactured ...

How large-scale technology projects affect knowledge

Oct 21, 2014

What do an accelerator complex at Cern, a manufacturing center in 19th century Philadelphia and lotus cultivation during the Qing dynasty all have in common? All such activities generate knowledge and know-how. ...

Recommended for you

New approach to particle therapy dosimetry

Dec 19, 2014

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Supplement maker admits lying about ingredients

Dec 17, 2014

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.